G.D. Utrosin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
G.D. Utrosin has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Anastasia S. Fatyanova
The Department of Oncology, Radiotherapy and Reconstructive Surgery, I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., Bldg. 8/2, 119991 Moscow, Russia
1 shared publication - Andrey Pavlovich Fabrika
I.M. Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication - E.I. Dybalyuk
I.M. Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication - Evgeniy A. Tarabrin
Department of Hospital Surgery No. 2, Sechenov First Moscow State Medical University (Sechenov University), 119048 Moscow, Russia
1 shared publication - K. A. Kammaev
Sechenov University
1 shared publication - Sergey Yu. Muraviev
Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication
Latest Publications
- 20 February 2026
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 15 (1)
A pathomorphological complete response to neoadjuvant chemotherapy with carboplatin plus paclitaxel in stage IIIA central squamous cell carcinoma of the lung
The article presents a rare clinical case of examination and treatment of a patient with stage IIIA lung squamous cell carcinoma. After neoadjuvant chemotherapy using the standard regimen of paclitaxel-carboplatin (6 injections), a complete pathomorphological response was achieved based on the results of histological and immunohistochemical examination of the postoperative material. During 12 months of follow-up, no recurrences were observed. In light of the results obtained, the issue of the potential benefits of omitting the surgical treatment stage after achieving a complete pathomorphological response to neoadjuvant chemotherapy is raised. Further prospective studies are needed to confirm these conclusions.
- 20 February 2026
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 15 (1)
A pathomorphological complete response to neoadjuvant chemotherapy with carboplatin plus paclitaxel in stage IIIA central squamous cell carcinoma of the lung
The article presents a rare clinical case of examination and treatment of a patient with stage IIIA lung squamous cell carcinoma. After neoadjuvant chemotherapy using the standard regimen of paclitaxel-carboplatin (6 injections), a complete pathomorphological response was achieved based on the results of histological and immunohistochemical examination of the postoperative material. During 12 months of follow-up, no recurrences were observed. In light of the results obtained, the issue of the potential benefits of omitting the surgical treatment stage after achieving a complete pathomorphological response to neoadjuvant chemotherapy is raised. Further prospective studies are needed to confirm these conclusions.